Guidelines

Bartell Drugs urges vaccination as measles outbreak hits Washington
Bartell Drugs is prepared to administer the measles, mumps and rubella vaccine to help stop the spread of measles in Washington state, the company said.
USP launches its Generics Access Plan
USP's Generics Access Plan intends to facilitate generics competition by collaborating with the Food and Drug Administration to develop and revise quality standards.

FDA approves new Alimta indication

The FDA's approval of Lilly’s Alimta in combination with Merck's Keytruda, and platinum chemotherapy, is a breakthrough for patients with lung cancer.
FDA head renews push for generics competition

The FDA is continuing its push to increase development and approval of generics and biosimilars.
FDA OKs Mylan's Wixela Inhub, the first generic Advair Diskus

Mylan’s generic Advair Diskus is the first generic drug product approved for one of the most commonly prescribed asthma and COPD inhalers.
Kroger pharmacies, clinics to roll out point-of-care blood testing

The company this week announced that it would be rolling out PTS Diagnostics' CardioCheck Plus analyzers to pharmacies and clinics, which will help identify whether patients are at risk of a heart attack, a stroke or diabetes at the point of care.
Mayne Pharma launches Tolsura

Mayne's launch of Tolsura provides a new treatment to fight life-threatening fungal infections.
NASP weighs in on DIR fee reform in comments to CMS

The National Association of Specialty Pharmacy has submitted its comments to the Centers for Medicare and Medicaid Services in response to the agency’s proposed Medicare Part D rule reform.
Hikma launches mitomycin for injection

Hikma has introduced mitomycin for injection, a cancer treatment that had a market value of roughly $43 million for the year ended November 2018, according to IQVIA data.
NCPA: Nearly 3,500 pharmacists voice support for DIR proposal

NCPA's efforts to build support for parts of the Center for Medicare and Medicaid Services' drug pricing rule involving DIR fees has drawn wide support among pharmacists and stakeholders.

Bartell Drugs urges vaccination as measles outbreak hits Washington

USP launches its Generics Access Plan

FDA approves new Alimta indication

FDA head renews push for generics competition

FDA OKs Mylan's Wixela Inhub, the first generic Advair Diskus

Kroger pharmacies, clinics to roll out point-of-care blood testing

Mayne Pharma launches Tolsura

NASP weighs in on DIR fee reform in comments to CMS

Hikma launches mitomycin for injection

NCPA: Nearly 3,500 pharmacists voice support for DIR proposal